Clinical trial
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic…
NCT00329498 · Samsung Medical Center, Other · Suspended
Key facts
| NCT number | NCT00329498 |
|---|---|
| Title | L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes |
| Official title | Manipulation of L-Ascorbic Acid Level For The Treatment of Selected Cases Of Acute Myeloid Leukemia and Myelodysplastic Syndromes |
| Lead sponsor | Samsung Medical Center, Other |
| Collaborators | Jin Yang Pharmaceutical Industry |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Myelodysplastic Syndrome |
| Intervention type | Drug |
| Interventions | L-Ascorbic Acid |
| Enrollment | 25 |
| Start date | May 1, 1998 |
| Completion | Aug 1, 2005 |
| First posted | May 24, 2006 |
| Last update posted | Oct 26, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: